Changing Hospital Dynamics Driving the Need for Sophisticated Patient Monitoring Devices
Posted on: Wednesday, 11 June 2008, 12:00 CDT
Research and Markets http://www.researchandmarkets.com/research/d613f1/north_american_pat has announced the addition of Frost & Sullivan's new report "North American Patient Monitoring Industry - Investment Analysis" to their offering.
This Frost & Sullivan research service titled North American Patient Monitoring Industry - Investment Analysis provides an analysis of the key investment themes, merger and acquisition history, and various valuation indicators of patient monitoring companies. In this research, Frost & Sullivan's expert analysts thoroughly examine the following segments: multiparameter monitoring equipment, cardiovascular monitoring equipment, sleep apnea monitoring equipment, diabetes blood glucose monitoring equipment, blood pressure monitoring equipment, temperature monitoring equipment, anesthesia monitoring equipment, pulse oximetry and capnography monitoring equipment, ambulatory telemetry monitoring equipment, and EEG diagnostic and monitoring equipment.
Market Overview
A rise in the level of acuity amongst patients, coupled with an acute shortage of nurses, is leading to an increased demand for sophisticated patient monitoring solutions in North America. Multiparameter patient monitoring equipment can help manage a nurse's time more efficiently by eliminating the documentation tasks. Furthermore, the convergence of information technology (IT) with patient monitoring systems saves valuable time by sending vital patient information directly into a patient's medical record. Wireless monitoring systems also help by reducing overcrowding in higher acuity areas. With these sytems, patients can be monitored anywhere in the hospital, thus freeing up critical space.
Latent Opportunities in Sleep Apnea Diagnostics
The sleep apnea segment also holds significant investment opportunity as one in every five adults in the United States suffers from some form of obstructive sleep apnea (OSA). Despite its high prevalence, there is a general lack of awareness about OSA. Industry sources estimate that less than 10 percent of people suffering from this disease have been diagnosed or treated, thus creating a huge market opportunity for device manufacturers. "The Centers for Medicare and Medicaid Services have decided to subsidize continuous positive airway pressure (CPAP) devices to elderly and disabled people receiving treatment at home," notes the analyst of this research service. "Favorable regulation, increased knowledge about this breathing disorder together with the emergence of new alternatives to current diagnostics tools is set to aid in market expansion."
Diabetes Glucose Monitoring Market Expected to Witness Strong Growth
Incidence of diabetes within the United States has increased by about 50.0 percent between 1998 and 2005 and an estimated 54.0 million people suffered from pre-diabetes in 2005. According to the National Diabetes Education Program, diabetes could potentially grow at 10.0 percent a year if left untreated. This large population base creates a continuous demand for blood glucose self-monitoring devices. Furthermore, alternate site testing (thigh and forearm) has lowered the perception of pain and in turn bolstered the development of the market. Technological advancements such as continuous blood glucose monitoring and non-invasive blood glucose monitoring are also spurring interest among the healthcare community, thus contributing to further growth in the diabetes glucose self-monitoring market.
Overall, the North American patient monitoring industry is expected to demonstrate a growth rate of 7.2 percent for the period 2007-2012. "The sleep apnea, hospital wireless monitoring, and diabetes blood glucose monitoring segments are the ones with the highest growth potential in the North American patient monitoring industry," says the analyst. "An underdiagnosis of sleep apnea, overcrowded higher acuity areas, and an increasing prevalence of diabetes are the major factors driving growth in these segments."
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
-- Multiparameter monitoring equipment
-- Cardiovascular monitoring equipment
-- Sleep apnea monitoring equipment
-- Diabetes blood glucose monitoring equipment
-- Blood pressure monitoring equipment
-- Temperature monitoring equipment
-- Anesthesia monitoring equipment
-- Pulse oximetry and capnography monitoring equipment
-- Ambulatory telemetry monitoring equipment
-- EEG diagnostic and monitoring equipment
Key Topics Covered: Executive Summary 1. Executive Summary Introduction and Methodology 1. Introduction 2. Methodology Industry Fundamentals 1. Industry Fundamentals 2. Industry Overview 3. Frost & Sullivan Patient Monitoring Equipment Growth Monitor 4. Industry Growth Outlook Investment Opportunities 1. Investment Themes 2. Investment Scorecard 3. Company Scorecard 4. Profiles of Diabetes Glucose Monitoring Companies 5. Merger and Acquisition Analysis 6. Mergers and Acquisitions
For more information visit http://www.researchandmarkets.com/research/d613f1/north_american_pat
Source: Business Wire
Related Articles
- Exforge(R) Helps Nearly Twice As Many Patients Control Their High Blood Pressure Compared to Amlodipine Alone
- Analyse the Market Trends in the North American Multiparameter Patient Monitoring Equipment Markets
- DexCom(TM) Receives FDA Approval to Calibrate Its SEVEN(TM) Continuous Glucose Monitoring System Using Any FDA Cleared Blood Glucose Meter
- MedApps D-PAL(TM) Remote Patient Monitoring System for Diabetes Cleared for Over-the-Counter Use By FDA
- Self-monitoring benefits patients on blood-thinners
- China's Steel Industry Keeps Fast Growth in First 3 Quarters of 2005
- China's Steel Industry Reports "Fast Growth" in 2005
- MRSA Risk Doubled in Critically Ill Patients with Glucose in Their Airways
- DPS Telecom and Chronos Technology Join Forces to Market Network Alarm Monitoring Equipment in UK and Europe
- Determinants of Diabetes-Attributable Non-Blood Glucose-Lowering Medication Costs in Type 2 Diabetes: The Fremantle Diabetes Study
User Comments (0)

RSS Feeds